Global Tuberculosis Diagnostics and Treatment Market Analysis & Trends- Therapeutics, Diagnosis - Forecast to 2025

  • ID: 3971829
  • Report
  • Region: Global
  • 137 pages
  • Accuray Research LLP
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories,
  • Alere, Inc
  • bioMérieux SA
  • EIKEN Chemical
  • F. Hoffmann-La Roche AG
  • Hain LifeSciences
  • MORE
"Global Tuberculosis Diagnostics and Treatment Market Analysis & Trends- Therapeutics (Rifampin (RIF), Pyrazinamide (PZA), Thioamides and Fluoroquinolones), Diagnosis (Nucleic Acid Amplification Tests (NAAT), Smear Microscopy and Biomarkers) - Forecast to 2025"

The Global Tuberculosis Diagnostics and Treatments Market is poised to grow at a CAGR of around 4.2% from 2015 to 2025. Some of the prominent trends that the market is Technologies that may replace smear microscopy continue to expand, Major investments in basic research related to Mycobaterium tuberculosis diagnosis, Demand for Xpert MTB/RI in the tuberculosis diagnostics landscape and Potential Market in Most of the Emerging Nations of the World.

Based on Therapeutics the market is categorized into Tuberculosis Drugs (First Line) and Tuberculosis Drugs (Second Line). The Tuberculosis Drugs (First Line) segment is Isoniazid (INH), Rifampin (RIF), Ethambutol (EMB) and Pyrazinamide (PZA). Tuberculosis Drugs (Second Line) segment is further represented as Aminoglycosides, Fluoroquinolones, Polypeptides, Thioamides, Cycloserine, p-Aminosalicylic Acid and Other Drugs.

Based on Diagnosis the market is categorized into Skin Testing and Laboratory Testing. The Laboratory Testing segment is further categorized into Adenosine Deaminas, Nucleic Acid Amplification Tests (NAAT), Interferon Gamma Release Assay, Antibody/Antigen Detection, Culture-Based Systems, Non-Culture Methods, Chest X-rays and computer-aided diagnosis, Biomarkers for active or latent TB, Serodiagnostic assays, Microscopy and associated tools, Cytokine detection assay, Smear Microscopy and Drug Susceptibility Testing (DST).

This industry report analyzes the global markets for Tuberculosis Diagnostics across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The Tuberculosis Diagnostics Market report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
- Africa
- Caribbean

Report Highlights:

- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories,
  • Alere, Inc
  • bioMérieux SA
  • EIKEN Chemical
  • F. Hoffmann-La Roche AG
  • Hain LifeSciences
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 End User Analysis
1.5 Application Analysis
1.6 Strategic Benchmarking
1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Technologies that may replace smear microscopy continues to expand
3.1.2 Major investments in basic research related to Mycobacterium tuberculosis diagnosis
3.1.3 Demand for Xpert MTB/RI in the tuberculosis diagnostics landscape
3.1.4 Potential Market in Most of the Emerging Nations of the World
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Tuberculosis Diagnostics and Treatments Market, By Therapeutics
4.1 Tuberculosis Drugs (First Line)
4.1.1 Tuberculosis Drugs (First Line) Market Forecast to 2025 (US$ MN)
4.1.1.1 Isoniazid (INH)
4.1.1.1.1 Isoniazid (INH) Market Forecast to 2025 (US$ MN)
4.1.1.2 Rifampin (RIF)
4.1.1.2.1 Rifampin (RIF) Market Forecast to 2025 (US$ MN)
4.1.1.3 Ethambutol (EMB)
4.1.1.3.1 Ethambutol (EMB) Market Forecast to 2025 (US$ MN)
4.1.1.4 Pyrazinamide (PZA)
4.1.1.4.1 Pyrazinamide (PZA) Market Forecast to 2025 (US$ MN)
4.2 Tuberculosis Drugs (Second Line)
4.2.1 Tuberculosis Drugs (Second Line) Market Forecast to 2025 (US$ MN)
4.2.1.1 Aminoglycosides
4.2.1.1.1 Aminoglycosides Market Forecast to 2025 (US$ MN)
4.2.1.2 Fluoroquinolones
4.2.1.2.1 Fluoroquinolones Market Forecast to 2025 (US$ MN)
4.2.1.3 Polypeptides
4.2.1.3.1 Polypeptides Market Forecast to 2025 (US$ MN)
4.2.1.4 Thioamides
4.2.1.4.1 Thioamides Market Forecast to 2025 (US$ MN)
4.2.1.5 Cycloserine
4.2.1.5.1 Cycloserine Market Forecast to 2025 (US$ MN)
4.2.1.6 p-Aminosalicylic Acid
4.2.1.6.1 p-Aminosalicylic Acid Market Forecast to 2025 (US$ MN)
4.2.1.7 Other Drugs
4.2.1.7.1 Other Drugs Market Forecast to 2025 (US$ MN)

5 Tuberculosis Diagnostics and Treatments Market, By Diagnosis
5.1 Skin Testing
5.1.1 Skin Testing Market Forecast to 2025 (US$ MN)
5.2 Laboratory Testing
5.2.1 Laboratory Testing Market Forecast to 2025 (US$ MN)
5.2.1.1 Adenosine Deaminase
5.2.1.1.1 Adenosine Deaminase Market Forecast to 2025 (US$ MN)
5.2.1.2 Nucleic Acid Amplification Tests (NAAT)
5.2.1.2.1 Nucleic Acid Amplification Tests (NAAT) Market Forecast to 2025 (US$ MN)
5.2.1.3 Interferon Gamma Release Assay
5.2.1.3.1 Interferon Gamma Release Assay Market Forecast to 2025 (US$ MN)
5.2.1.4 Antibody/Antigen Detection
5.2.1.4.1 Antibody/Antigen Detection Market Forecast to 2025 (US$ MN)
5.2.1.5 Culture-Based Systems
5.2.1.5.1 Culture-Based Systems Market Forecast to 2025 (US$ MN)
5.2.1.6 Non-Culture Methods
5.2.1.6.1 Non-Culture Methods Market Forecast to 2025 (US$ MN)
5.2.1.7 Chest X-rays and computer-aided diagnosis
5.2.1.7.1 Chest X-rays and computer-aided diagnosis Market Forecast to 2025 (US$ MN)
5.2.1.8 Biomarkers for active or latent TB
5.2.1.8.1 Biomarkers for active or latent TB Market Forecast to 2025 (US$ MN)
5.2.1.19 Serodiagnostic assays
5.2.1.19.1 Serodiagnostic assays Market Forecast to 2025 (US$ MN)
5.2.1.10 Microscopy and associated tools
5.2.1.10.1 Microscopy and associated tools Market Forecast to 2025 (US$ MN)
5.2.1.11 Cytokine detection assay
5.2.1.11.1 Cytokine detection assay Market Forecast to 2025 (US$ MN)
5.2.1.12 Smear Microscopy
5.2.1.12.1 Smear Microscopy Market Forecast to 2025 (US$ MN)
5.2.1.13 Drug Susceptibility Testing (DST)
5.2.1.13.1 Drug Susceptibility Testing (DST) Market Forecast to 2025 (US$ MN)

6 Tuberculosis Diagnostics and Treatments Market, By Geography
6.1 North America
6.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
6.1.1.1 US
6.1.1.2 Canada
6.1.1.3 Mexico
6.2 Europe
6.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
6.2.1.1 France
6.2.1.2 Germany
6.2.1.3 Italy
6.2.1.4 Spain
6.2.1.5 UK
6.2.1.6 Rest of Europe
6.3 Asia Pacific
6.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
6.3.1.1 China
6.3.1.2 Japan
6.3.1.3 India
6.3.1.4 Australia
6.3.1.5 New Zealand
6.3.1.6 Rest of Asia
6.4 Middle East
6.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
6.4.1.1 Saudi Arabia
6.4.1.2 UAE
6.4.1.3 Rest of Middle East
6.5 Latin America
6.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
6.5.1.1 Argentina
6.5.1.2 Brazil
6.5.1.3 Rest of Latin America
6.6 Rest of the World (RoW)
6.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)
6.6.1.1 Africa
6.6.1.2 Caribbean

7 Key Player Activities
7.1 Acquisitions & Mergers
7.2 Agreements, Partnerships, Collaborations and Joint Ventures
7.3 Product Launch & Expansions
7.4 Other Activities

8 Leading Companies
8.1 Cepheid Inc
8.2 Becton Dickinson
8.3 Hain LifeSciences
8.4 Abbott Laboratories,
8.5 Alere, Inc
8.6 F. Hoffmann-La Roche AG
8.7 Hologic Corporation
8.8 bioMérieux SA
8.9 Sanofi
8.10 QIAGEN
8.11 Akonni Biosystems, Inc.
8.12 Epistem Holdings Plc
8.13 Gen-Probe Inc.
8.14 EIKEN Chemical
8.15 Thermo Fisher Scientific, Inc

List of Tables

Table 1 Global Tuberculosis Diagnostics and Treatments Market By Region, Market Forecast (2013-2025) (US $MN)
Table 2 Global Tuberculosis Diagnostics and Treatments Market By Therapeutics, Market Forecast (2013-2025) (US $MN)
Table 3 Global Tuberculosis Diagnostics and Treatments Market By Tuberculosis Drugs (First Line), Market Forecast (2013-2025) (US $MN)
Table 4 Global Tuberculosis Diagnostics and Treatments Market By Isoniazid (INH), Market Forecast (2013-2025) (US $MN)
Table 5 Global Tuberculosis Diagnostics and Treatments Market By Rifampin (RIF), Market Forecast (2013-2025) (US $MN)
Table 6 Global Tuberculosis Diagnostics and Treatments Market By Ethambutol (EMB), Market Forecast (2013-2025) (US $MN)
Table 7 Global Tuberculosis Diagnostics and Treatments Market By Pyrazinamide (PZA), Market Forecast (2013-2025) (US $MN)
Table 8 Global Tuberculosis Diagnostics and Treatments Market By Tuberculosis Drugs (Second Line), Market Forecast (2013-2025) (US $MN)
Table 9 Global Tuberculosis Diagnostics and Treatments Market By Aminoglycosides, Market Forecast (2013-2025) (US $MN)
Table 10 Global Tuberculosis Diagnostics and Treatments Market By Fluoroquinolones, Market Forecast (2013-2025) (US $MN)
Table 11 Global Tuberculosis Diagnostics and Treatments Market By Polypeptides, Market Forecast (2013-2025) (US $MN)
Table 12 Global Tuberculosis Diagnostics and Treatments Market By Thioamides, Market Forecast (2013-2025) (US $MN)
Table 13 Global Tuberculosis Diagnostics and Treatments Market By Cycloserine, Market Forecast (2013-2025) (US $MN)
Table 14 Global Tuberculosis Diagnostics and Treatments Market By p-Aminosalicylic Acid, Market Forecast (2013-2025) (US $MN)
Table 15 Global Tuberculosis Diagnostics and Treatments Market By Other Drugs, Market Forecast (2013-2025) (US $MN)
Table 16 Global Tuberculosis Diagnostics and Treatments Market By Diagnosis, Market Forecast (2013-2025) (US $MN)
Table 17 Global Tuberculosis Diagnostics and Treatments Market By Skin Testing, Market Forecast (2013-2025) (US $MN)
Table 18 Global Tuberculosis Diagnostics and Treatments Market By Laboratory Testing, Market Forecast (2013-2025) (US $MN)
Table 19 Global Tuberculosis Diagnostics and Treatments Market By Adenosine Deaminase, Market Forecast (2013-2025) (US $MN)
Table 20 Global Tuberculosis Diagnostics and Treatments Market By Nucleic Acid Amplification Tests (NAAT), Market Forecast (2013-2025) (US $MN)
Table 21 Global Tuberculosis Diagnostics and Treatments Market By Interferon Gamma Release Assay, Market Forecast (2013-2025) (US $MN)
Table 22 Global Tuberculosis Diagnostics and Treatments Market By Antibody/Antigen Detection, Market Forecast (2013-2025) (US $MN)
Table 23 Global Tuberculosis Diagnostics and Treatments Market By Culture-Based Systems, Market Forecast (2013-2025) (US $MN)
Table 24 Global Tuberculosis Diagnostics and Treatments Market By Non-Culture Methods, Market Forecast (2013-2025) (US $MN)
Table 25 Global Tuberculosis Diagnostics and Treatments Market By Chest X-rays and computer-aided diagnosis, Market Forecast (2013-2025) (US $MN)
Table 26 Global Tuberculosis Diagnostics and Treatments Market By Biomarkers for active or latent TB, Market Forecast (2013-2025) (US $MN)
Table 27 Global Tuberculosis Diagnostics and Treatments Market By Serodiagnostic assays, Market Forecast (2013-2025) (US $MN)
Table 28 Global Tuberculosis Diagnostics and Treatments Market By Microscopy and associated tools, Market Forecast (2013-2025) (US $MN)
Table 29 Global Tuberculosis Diagnostics and Treatments Market By Cytokine detection assay, Market Forecast (2013-2025) (US $MN)
Table 30 Global Tuberculosis Diagnostics and Treatments Market By Smear Microscopy, Market Forecast (2013-2025) (US $MN)
Table 31 Global Tuberculosis Diagnostics and Treatments Market By Drug Susceptibility Testing (DST), Market Forecast (2013-2025) (US $MN)

Note: The Europe, Asia Pacific, Middle East, Latin America and RoW tables are in above manner
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories,
  • Akonni Biosystems, Inc.
  • Alere, Inc
  • Becton Dickinson
  • Cepheid Inc
  • EIKEN Chemical
  • Epistem Holdings Plc
  • F. Hoffmann-La Roche AG
  • Gen-Probe Inc.
  • Hain LifeSciences
  • Hologic Corporation
  • QIAGEN
  • Sanofi
  • Thermo Fisher Scientific, Inc
  • bioMérieux SA
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll